Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of FBT will - over the next 2 Weeks and hit - by . In that time frame, FBT's share price is expected to range between - and -.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No Data | |||||||||||||||||||
FBT shares fell -1.24% in Thursday, September 10, 2026's trading session, dropping from a previous close of $265.56 to move at $262.28. The stock demonstrated notable intraday movement (see FBT's key stats for a full breakdown), fluctuating between $261.82 and $264.52, a +1.03% trading range. While recent weeks have seen some volatility, FBT has managed to secure a -4.25% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 53.56K shares changing hands, 35.2K more than the previous session. This amounted to $14.05M in total market activity.
Will FBT Continue Its Trend?
According to analyst ratings and projections for FBT, First Trust NYSE Arca Biotechnology Index Fund shares are anticipated to remain stable by -, potentially reaching - per share by January 1, 1970. Short-term technical indicators currently suggest a bearish sentiment for FBT. However, the stock has recorded 18 positive trading days within the past 30 sessions. Based on the FBT stock forecast, now is not the best time to buy FBT stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on FBT covering social and institutional perspectives.
FBT Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into FBT's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 40.62% to 52.51%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 57.61%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 57.67%, maintains a neutral outlook for the long term. Insights into FBT's shareholder base show how institutional investors are positioning themselves during these momentum shifts

